Skip to main content
. Author manuscript; available in PMC: 2020 Dec 8.
Published in final edited form as: World J Urol. 2015 Jan 6;33(10):1503–1509. doi: 10.1007/s00345-014-1475-2

Fig. 1.

Fig. 1

Follow-up scheme as proposed by the panel: #Patient selection for focal therapy is not a topic of this consensus project. When biopsies in the follow-up proof recurrent or residual disease, the treating physician should evaluate the treatment options again. *Assessment of incontinence by either 24-h pad weight test (most objective test and advised as optimum), or number of pads used per day